What are the risks and side effects of starting TRT in your 30s?

Short answer upfront: TRT can relieve symptoms of low testosterone, but in your 30s it carries important risks — most notably suppression of sperm production (infertility), testicular shrinkage, increased red blood cell count, and possible cardiovascular, sleep‑apnea and prostate effects. Many other side effects are common but manageable with monitoring. Discuss risks and fertility goals with an experienced clinician before starting.

Common side effects

• Acne, oily skin, and increased facial/body hair.
• Fluid retention / mild edema.
• Mood changes: irritability, increased aggression or swings in mood in some people.
• Scalp hair loss or acceleration of male‑pattern baldness (if genetically predisposed).
• Local reactions: skin irritation from gels/patches; injection‑site pain.

Fertility and reproductive system

• Suppression of LH/FSH → marked reduction in spermatogenesis and semen volume. This can cause infertility; recovery after stopping TRT may take months to years and is not guaranteed. If you might want children, consider alternatives (below) or sperm banking first.
• Testicular atrophy (shrinkage) is common while on TRT.

Hematologic

• Erythrocytosis / polycythemia (increased hematocrit) — raises blood clot, stroke and heart‑attack risk if untreated. Requires periodic CBC monitoring; doses may be reduced or therapy paused or managed with phlebotomy.

Cardiovascular and metabolic

• Evidence about heart risks is mixed. Some studies suggest increased risk of cardiovascular events in men with pre‑existing heart disease; causality is uncertain. Discuss personal CV risk factors (hypertension, smoking, high cholesterol, diabetes) with your clinician.
• TRT can lower HDL and alter lipids in some people.

Prostate and cancer considerations

• TRT typically raises PSA slightly. Historically there was concern about provoking prostate cancer; current evidence doesn’t show TRT causes prostate cancer but it’s usually avoided in men with known prostate cancer and monitored with PSA checks.

Respiratory

• Can worsen or reveal obstructive sleep apnea.

Other

• Rarely, venous thromboembolism (blood clots) risk may increase.
• Oral alkylated androgens (rarely used) carry higher liver toxicity; modern gels/injections are much less hepatotoxic.

Monitoring and precautions (what a responsible prescriber should do)

• Baseline tests: two morning total testosterone measurements, free testosterone as needed, LH/FSH, prolactin (if low T), CBC, CMP/liver tests, lipid panel, PSA, and assessment for sleep apnea if risk factors exist. Consider baseline semen analysis if you may want fertility later.
• Ongoing: testosterone level and symptom check at ~3 months after start/adjustment, then every 6–12 months; CBC at 3 months then periodically; PSA per age/risk guidelines; monitor blood pressure, lipids, and mood/sleep.
• Contraindications: active prostate or breast cancer, uncontrolled severe heart failure, untreated severe sleep apnea — discuss individually.

Alternatives if fertility is a concern or to try first

• Clomiphene citrate (Clomid, Serophene) — oral SERM that can raise endogenous testosterone while preserving sperm production in many men.
• Human chorionic gonadotropin (hCG, brand examples: Ovidrel, Pregnyl) — used to maintain/testicular function or with TRT to preserve fertility.
• Address reversible causes: weight loss, treat sleep apnea, optimize sleep, treat opiate use or other meds that lower testosterone, manage alcohol and steroids.

Common TRT product types and example brand names (discuss options with your prescriber)

• Topical gels: AndroGel, Testim, Fortesta — easy to use, steady levels, but risk of transferring to others by skin contact.
• Patches: Androderm — daily patch; can irritate skin.
• Intramuscular injections: testosterone cypionate or enanthate (often given as generics or Depo‑Testosterone) — inexpensive and commonly used.
• Long‑acting intramuscular testosterone undecanoate: Aveed (US)/Nebido (other countries) — less frequent dosing but requires clinic visits and has specific administration rules.
• Subcutaneous pellets: Testopel — implanted by a provider and release testosterone over months.

Who to see / where to get care

• Endocrinologist or urologist experienced in male hypogonadism or a reproductive/urology clinic if fertility is a concern. Reputable centers: Mayo Clinic Endocrinology/Urology, Cleveland Clinic Male Reproductive Medicine, or an academic medical center near you. For fertility preservation consult a reproductive endocrinologist/andrologist.

Practical next steps

1. Get confirmed low testosterone with morning labs (2 measurements) and evaluation for secondary causes.
2. Discuss fertility plans; consider semen analysis and fertility‑preserving options before starting TRT.
3. If you and your clinician decide on TRT, arrange baseline labs and a monitoring schedule.
4. If preserving fertility, ask about clomiphene or hCG alternatives or using hCG with TRT.

If you want, tell me: do you already have lab results (testosterone value, symptoms, plans for kids)? I can help interpret or outline specific monitoring steps and which product types might fit your priorities.